Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rong Fan
Jinlin Hou

Showing results (1-10 of 1,296) with videos related to

Pageof 130
Sort By:
Hepatology International|April 19, 2020
Stopping oral antiviral treatment to cure chronic hepatitis B, is it in sight?Rong Fan, Jinlin Hou
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2020
ReplyRong Fan, Jinlin Hou
Alimentary Pharmacology & Therapeutics|August 11, 2021
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy-authors' replyRong Fan, Jinlin Hou
The New England Journal of Medicine|October 13, 2016
Prevention of Peripartum Hepatitis B TransmissionRong Fan, Xueru Yin, Jinlin Hou
Frontiers of Medicine|May 10, 2014
Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in ChinaRui Yu, Rong Fan, Jinlin Hou
Journal of Hepatology|January 16, 2021
Reply to: "External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs"Rong Fan, Xueru Yin, Jinlin Hou
Gastroenterology|March 31, 2016
Combination Therapy With Tenofovir and Peginterferon May Not Be Translated Into Current Clinical PracticeRong Fan, Jian Sun, Jinlin Hou
Journal of Gastroenterology and Hepatology|June 15, 2012
Prevention and management of drug resistant hepatitis B virus infectionsCheng Wang, Rong Fan, Jian Sun, et al.
The Lancet. Infectious Diseases|September 28, 2016
A hepatitis B-free generation in China: from dream to realityRong Fan, Xueru Yin, Zhihong Liu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|June 16, 2012
[Influence of adefovir dipivoxil or telbivudine monotherapy on renal function of patients with chronic hepatitis B]Xiaoxi Li, Chunxiu Zhong, Shuling Yang, et al.
Pageof 130

Showing results (1-10 of 1,296) with videos related to

Sort By:
Pageof 130
Hepatology International|April 19, 2020
Stopping oral antiviral treatment to cure chronic hepatitis B, is it in sight?Rong Fan, Jinlin Hou
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2020
ReplyRong Fan, Jinlin Hou
Alimentary Pharmacology & Therapeutics|August 11, 2021
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy-authors' replyRong Fan, Jinlin Hou
The New England Journal of Medicine|October 13, 2016
Prevention of Peripartum Hepatitis B TransmissionRong Fan, Xueru Yin, Jinlin Hou
Frontiers of Medicine|May 10, 2014
Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in ChinaRui Yu, Rong Fan, Jinlin Hou
Journal of Hepatology|January 16, 2021
Reply to: "External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs"Rong Fan, Xueru Yin, Jinlin Hou
Gastroenterology|March 31, 2016
Combination Therapy With Tenofovir and Peginterferon May Not Be Translated Into Current Clinical PracticeRong Fan, Jian Sun, Jinlin Hou
Journal of Gastroenterology and Hepatology|June 15, 2012
Prevention and management of drug resistant hepatitis B virus infectionsCheng Wang, Rong Fan, Jian Sun, et al.
The Lancet. Infectious Diseases|September 28, 2016
A hepatitis B-free generation in China: from dream to realityRong Fan, Xueru Yin, Zhihong Liu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|June 16, 2012
[Influence of adefovir dipivoxil or telbivudine monotherapy on renal function of patients with chronic hepatitis B]Xiaoxi Li, Chunxiu Zhong, Shuling Yang, et al.
Pageof 130